Post Management Call Commentary and Updated Models
Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its strategy to become a leading vertically integrated cannabis holding company with a portfolio consisting of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Call w/Management. We remain enthusiastic about Schwazze following our conversation with CEO Justin Dye and CFO Nancy Huber. Management continues to increase market share, the implementation of the operating playbook is resulting in better than overall market performance, and there remains a defined pathway to get Schwazze to the $500 million revenue level.
MCG Acquisition. The Company is acquiring MCG, LLC for $29 million. Also known as Emerald Fields, MCG operates two dispensaries, one in Denver and one just outside of Colorado Springs, a market in which adult use dispensaries have yet to be approved. The Manitou Springs locations is reportedly one of the highest grossing locations in Colorado …
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.